本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
今年春夏最可愛的打卡話題登場！為慶祝布丁狗迎來出道30週年，CACO cafe特別攜手布丁狗推出期間限定主題空間，將布丁狗的世界搬進真實生活。現場除了吸睛場景與拍照打卡點，也同步推出多款主題餐點、以及粉絲期待的首波加價購及會員禮，讓開幕話題迅速在社群發酵。本次將於4月8日率先在台南南紡購物中心與新光三越台南西門新天地登場，4月10日接續進駐台中漢神洲際購物廣場與高雄夢時代購物中心，四間門市接力換上療癒場景。從門口到店內角落，走進CACO cafe就像闖進一座真實的布丁狗世界，絕對是今年最值得朝聖的情緒療癒據點。 圖說：CACO cafe將IP實體化，再創春夏暖萌話題！攜手三麗鷗超人氣明星布丁狗，搭上出道30週年話題，跨縣市打造期間限定主題門市，號召粉絲齊聚朝聖打卡。（資料來源：加州椰子集團） 布丁狗圓滾滾的外型和招牌微笑，加上慢悠悠的生活節奏，長年穩居三麗鷗人氣前段班。他所散發溫柔陪伴感，讓粉絲在忙碌日常中得以放慢腳步、找到情緒頓點。本次餐點以「輕鬆分享」的聚會氛圍作為設計主軸，推出多款期間限定主題餐點，鹹食包括白醬千層麵、風味披薩與香烤小點拼盤；甜點則凸顯角色特點，打造麵條布丁聖代杯、QQ棉被布朗尼、布丁生乳捲與銅鑼燒冰淇淋。飲品部分有布丁奶茶、布丁椪糖冰沙與莓果多多氣泡飲，搭配造型吸管或紙杯墊，每一杯都是鎂光燈焦點。台中漢神洲際店更推出分店限定霜淇淋聖代系列，為遠道而來的粉絲增添清爽甜蜜。透過這些餐點，CACO cafe打造沉浸式用餐體驗，讓粉絲在享受美味的同時，也能感受到布丁狗的療癒魅力。 不只餐點，CACO cafe還推出多款期間限定周邊。服飾包括布丁狗造型長襪、托特包、提袋與零錢包；小物則有造型筆記本、胸章等，讓療癒力可以穿上身，成為零距離的生活陪伴。吊飾娃娃、大型絨毛玩偶、療癒抱枕與盲盒收藏，每一款都值得帶回家，不只是可愛周邊，更是粉絲珍藏的限量紀念，隨時感受布丁狗陪伴。 現場還有雲朵手撕棉花糖、松露玉米濃湯風味米星星等特色伴手禮，以及期間限定互動設施，包括造型拍貼機、姓名貼機與主題打卡布景，讓粉絲離店後也能延續快樂回憶。 圖說：透過多樣化的服飾和生活小物等設計週邊，CACO cafe讓布丁狗專屬療癒力具象化，成為零距離的溫暖陪伴。（資料來源：加州椰子集團） 為回饋粉絲熱情，CACO cafe準備了兩波限量滿額加價購驚喜！ 第一波4月8日至6月30日，單筆消費滿999元即可349元加購「布丁狗毛毛手提包」 第二波5月22日至6月30日，單筆消費滿1,200元即可129元加購「布丁狗絨毛髮帶」 此外，更有布丁狗送給粉絲的專屬開幕見面禮！4月8日起加入會員並追蹤品牌社群，即可獲得CACO cafe手機支架，數量有限、送完為止。 圖說：來自布丁狗的專屬見面禮！開幕期間、兩波滿額加價購接力登場，包括毛毛手提包和造型絨毛髮帶，限時限量迎接粉絲搶購收藏。（資料來源：加州椰子集團） 「CACO cafe x 布丁狗」此次聯名、被視為加州椰子品牌銷肖像化經營的重要一步。透過與布丁狗合作，CACO cafe把IP文化從服飾延伸至餐飲與實體空間，讓粉絲能在生活中、更立體地感受品牌魅力。隨著布丁狗30週年熱潮來襲，期間限定門市也將成為粉絲打卡新熱點。包括全新開幕的台中漢神洲際購物中心在內，全台四大指標商場接力登場，讓布丁狗的療癒魅力一路擴散，消息一曝光，勢必成為下一波不去會後悔的打卡話題！ 【CACO CAFE門市資訊】 CACO cafe台南新光三越小西門店（台南市中西區西門路一段658-1號B1） 檔期:2026/4/08(三)-6/30(二) CACO cafe台南南紡店（台南市東區中華東路一段366號1F） 檔期:2026/4/08(三)-6/30(二) CACO cafe高雄夢時代店（高雄市前鎮區中華五路789號2F） 檔期:2026/4/10(五)-6/30(二) CACO cafe台中漢神洲際店（台中市北屯區崇德路三段865號5F） 檔期:2026/4/10(五)-6/30(二)
在快節奏的城市日常裡，療癒不再只是口號，而是一種可以被穿上、被帶走、也能坐下來好好停留的生活提案。加州椰子集團旗下三大品牌，包括CACO、WAVE SHINE、CACO Cafe，攜手泰國超人氣療癒IP「Butterbear」，首度在台推出跨足服裝與餐飲聯名的「城市療癒計畫」，以「城市×療心×小熊Butterbear」為主軸，首站將於1月14日在新光三越台南西門新天地開幕，隨後也會巡迴至高雄夢時代、台北101、台北東區與台南南紡，讓Butterbear走進城市每個角落，成為日常生活中最溫暖的陪伴。 圖說：Butterbear跨界聯名攜手加州椰子三大品牌活動期間推出《城市療癒計畫》。（資料來源：加州椰子集團） 《Butterbear城市療癒計畫》不只是聯名合作，更像是一場將療癒與陪伴帶進日常的城市企劃。聯名期間，CACO、WAVE SHINE與CACO Cafe將以服裝、生活用品及餐飲三大面向，完整呈現Butterbear的療癒世界。從街頭穿搭到居家時光，再到咖啡香氣中停留的片刻，每一個細節都讓Butterbear成為日常中的暖心存在。 CACO以「像剛出爐的溫暖」為設計核心，將Butterbear的療癒形象轉化為日常可穿、好搭的服飾語言，推出印有可愛Butterbear圖案的T恤、襯衫、帽T、毛衣，以及具有造型感的水手領上衣、連身吊帶褲等款式，無論是通勤、假日外出或是旅行穿搭，溫潤色系和舒適剪裁的各種單品，都能輕鬆融入生活。同時，聯名還包括棒球帽、襪子和造型小包等周邊商品，把可愛延伸到日常生活每個細節。搭配聯名特別款滿額贈禮和會員活動，就能完整將Butterbear的溫暖帶回家。 圖說：CACO透過各式搭配單品輕鬆融入生活。（資料來源：加州椰子集團） WAVE SHINE則以品牌重點聚焦的「穿著感受」出發，將Butterbear所象徵的陪伴與安心，融入布料、剪裁與居家設計中。聯名系列品項不只涵蓋外出服飾，更強調營造舒適居家體驗，推出包括材質柔軟的內衣背心、睡衣套裝，以及Butterbear立體收納包、造型吊飾、室內拖鞋等生活配件，讓人在家也能感受到被溫柔包覆的安心感。放鬆不只是情緒的流動，而是能被身體真實感受到的狀態。透過這些和精神零距離的生活單品，Butterbear成為下班回家、週末放鬆等日常情境中，最溫柔暖心的陪伴。 圖說：WAVE SHINE從穿著感受出發材質更強調營造舒適居家體驗。（資料來源：加州椰子集團） CACO Cafe作為「城市裡的療心據點」，將Butterbear的世界觀具象化於空間、餐飲與甜點等設計之中，讓人走進店裡就能被柔軟分為包圍。聯名期間推出多款聯名品項，包括造型雞蛋糕、活動期間供應奶油咖啡、以及帶有泰式風味的打拋豬米漢堡，無論是視覺還是味覺、都能在這裡完成一場療癒小旅行。此外，活動期間提供伴手禮「Butterbear甜心萬用包禮盒」同步亮相，內含焦糖奶油糖、海鹽檸檬糖、毛絨化妝包、不織布購物袋及熊限定紅包袋一組（3入），無論是自用或送禮，都能一次把Butterbear的溫暖打包回家。 圖說：Butterbear甜心萬用包禮盒。（資料來源：加州椰子集團） 圖說：Butterbear活動期間供應伴手禮。（資料來源：加州椰子集團） 圖說：Butterbear活動期間供應餐點。（資料來源：加州椰子集團） 這次期間限定的聯名快閃企劃，不只是可愛角色合作，而是一場貼近生活、充滿柔和氛圍的舒心提案。穿上Butterbear的服裝，無論是在家或前往聯名咖啡廳享受甜點，生活每一刻都能感受到陪伴與安定。Butterbear像是城市中隨時可以依靠的小熊朋友，加州椰子集團透過這場複合式大型聯名活動，從穿搭到居家、從咖啡甜點到伴手禮，將整座城市打造成為療癒據點，千萬別錯過這場溫柔相遇企劃。 《Butterbear城市療癒計畫》 1. CACO Cafe首站檔期時間：台南小西門1/14~4/7 （台南市中西區西門路一段658-1號B1F） 2. CACO Cafe巡迴據點： 高雄夢時代檔期1/21~4/7（高雄市前鎮區中華五路789號2F） 台北101 檔期1/21~3/1（台北市信義區信義路5段7號B1樓） 台北東區檔期1/22~4/27（台北市大安區敦化南路1段219號） 台南南紡檔期1/23~4/7（台南市東區中華東路一段366號1F） 3. 活動期間供應菜單：泰式打拋豬米漢堡、Butterbear造型雞蛋糕、奶油咖啡、泰式奶茶、檸檬蜂蜜氣泡飲、蜂蜜柚子茶 4. 活動期間供應伴手禮：Butterbear 甜心萬用包禮盒、Butterbear熊甜蜜脆餅提袋禮盒、長崎蛋糕脆餅禮盒、蜂蜜蛋糕禮盒、海鹽檸檬糖、焦糖奶油糖 5. 滿額贈品(CACO cafe檔期)： 2026/01/14-2026/02/23滿1,000元即贈Butterbear咖啡小熊提袋 2026/02/24-2026/04/07滿1,000元即贈Butterbear圍裙小熊提袋 2026/01/14~2026/02/26滿2,000元即贈 Butterbear毛絨杯墊 2026/01/14起，一般會員消費滿3,000元升等禮；VIP/SVIP消費滿1,000元贈毛絨髮圈（送完為止） 2026/01/30~2026/02/13任意消費即贈Butterbear新年紅包袋 2026/01/30~2026/02/13消費滿888元即贈Butterbear福氣春聯 2026/02/01~2026/02/13消費滿888元即贈Butterbear新年刮刮樂 2026/01/30-2026/02/13加入好友即贈cafe手機支架
SINGAPORE, Sept. 26, 2024 /PRNewswire/ -- Caravelle International Group (Nasdaq: CACO), a global ocean technology company, today announced that its ordinary shares will begin trading on NASDAQ under the ticker symbol 'HTCO' prior to market open on September 30, 2024. This will replace the company's current ticker symbol 'CACO', which has been used since its de-SPAC transaction in 2022. No action by the company's shareholders is required with respect to the ticker symbol change. The company's ordinary shares will continue to be listed on NASDAQ, and the CUSIP and ISIN will remain unchanged. About Caravelle International Group Caravelle is a global ocean technology company with businesses in international shipping and marine carbon neutrality. The company is committed to improving shipping efficiency through innovative technologies and promoting sustainable development in the industry. Caravelle is headquartered in Singapore. Forward Looking Statements This announcement contains "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including, without limitation, those with respect to the objectives, plans and strategies of the Company set forth herein and those preceded by or that include the words "believe," "expect," "anticipate," "future," "will," "intend," "plan," "estimate" or similar expressions, are "forward-looking statements". Such statements include, but are not limited to risks detailed in the Company's filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 20-F for the fiscal year ended October 31, 2022. These forward-looking statements involve a number of risks and uncertainties, which could cause the Company's future results to differ materially from those anticipated. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. All information provided in this press release is as of the date of the publication, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
SINGAPORE, Aug. 29, 2023 /PRNewswire/ -- Caravelle International Group (Nasdaq: CACO), a global ocean technology company, today announced that it has received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), confirming that the Company has regained compliance with Nasdaq's filing requirement set forth in Listing Rule 5250(c)(1). As previously reported, the Company received a deficiency notice from Nasdaq on May 10, 2023, due to the delay in filing its Annual Report on Form 20-F for the fiscal year ended October 31, 2022. The Company was granted an extension until August 28, 2023, to file its Form 20-F and regain compliance. On August 28, 2023, the Company filed its Form 20-F and has now regained compliance with this Nasdaq's filing requirement. The Company wishes to thank its investors for their continued patience and support during this period. The management remains committed to maintaining the highest standards of corporate governance and transparency. About Caravelle International Group Caravelle is a global ocean technology company. Its business comprises of two sectors: the traditional business in international shipping, operated by the Topsheen Companies (Topsheen Shipping Group Corporation (Samoa) and its subsidiaries) and the new CO-Tech business under Singapore Garden Technology Pte. Ltd. As the traditional business, Caravelle's international shipping business has generated all revenues. The CO-Tech business is a new development building upon the existing shipping business. It enables wood desiccation during the maritime shipping process, with full utilization of the shipping time, space, and the waste heat of exhaust gas from the shipping vessels. Caravelle's CO-Tech industry has no historical operations and has not generated revenue. Caravelle is headquartered in Singapore. Forward Looking Statements This announcement contains "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including, without limitation, those with respect to the objectives, plans and strategies of the Company set forth herein and those preceded by or that include the words "believe," "expect," "anticipate," "future," "will," "intend," "plan," "estimate" or similar expressions, are "forward-looking statements". Such statements include, but are not limited to risks detailed in the Company's filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 20-F for the fiscal year ended October 31, 2022. These forward-looking statements involve a number of risks and uncertainties, which could cause the Company's future results to differ materially from those anticipated. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. All information provided in this press release is as of the date of the publication, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
SINGAPORE, May 25, 2023 /PR Newswire/ -- Caravelle International Group (Nasdaq: CACO), a global ocean technology company, today announced it has signed a supply agreement with South African company Best Polystyrene. Over the next two years, Caravelle will supply 50,000 cubic meters of wood from its processing facility in Gabon, West Africa, with an estimated revenue of $25 million. Caravelle will ship the wood products from Gabon, and in line with its innovative practices, will use its proprietary CO-Tech system to dry the wood in transit, offering significant cost savings and reducing lead times. The wood will then be delivered directly to Best Polystyrene in South Africa. Yang Liu, CEO of Best Polystyrene, commented on the agreement, "Our decision to partner with Caravelle for our wood sourcing was a strategic one. Their significant cost advantage, resulting from sourcing wood from Gabon and drying it in transit, not only cuts down on costs but also reduces lead times. This allows us to better serve our customers by offering quality products in a timely manner." Dr. Guohua Zhang, CEO of Caravelle International Group, expressed his enthusiasm about the agreement, stating, "This partnership with Best Polystyrene highlights our commitment to providing high-quality, cost-effective products and services globally. We look forward to working closely with Best Polystyrene over the next two years." Caravelle International Group continues to reinforce its commitment to innovative, efficient, and sustainable practices in all its operations. About Caravelle International Group Caravelle is a global ocean technology company. Its business comprises of two sectors: the traditional business in international shipping, operated by the Topsheen Companies (Topsheen Shipping Group Corporation (Samoa) and its subsidiaries) and the new CO-Tech business under Singapore Garden Technology Pte. Ltd.. As the traditional business, Caravelle's international shipping business has generated all revenues. The CO-Tech business is a new development building upon the existing shipping business. It enables wood desiccation during the maritime shipping process, with full utilization of the shipping time, space, and the waste heat of exhaust gas from the shipping vessels. Caravelle's CO-Tech industry has no historical operations and has not generated revenue. Caravelle is headquartered in Singapore. Forward Looking Statements This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements, including the successful consummation of the Company's initial public offering, are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.
SHANGHAI, Dec. 29, 2025 /PRNewswire/ -- Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to expand across a broader and more diverse therapeutic landscape. Viva Biotech has responded by building an integrated pharmacology platform that covers this end-to-end modality range, supporting programs from in vitro ADME assays through in vivo PK and efficacy studies. Adventures in DMPK: From Small Molecules and PROTACs to Peptides and Antibodies, the latest session in the Viva BioInsights webinar series, was presented by Dr. Justin Cui (Vice President of Pharmacology, Viva Biotech) and showcased these capabilities. Dr. Cui emphasized that small molecules, PROTACs, and peptides roughly share a common ADME/PK logic: physicochemical profiling and metabolic stability (e.g., microsomes, hepatocytes, S9/UGT, whole blood/plasma), permeability/transport (MDCK/Caco-2), DDI risk (CYP inhibition), and tailored exploratory assays, followed by multispecies PK with formulation screening. The differentiator is not the checklist, but the decision framework applied to large program volumes—using exposure metrics (e.g., AUC) and half-life to support early compound triage and deprioritization when profiles fall below internal thresholds. For peptide programs, Viva Biotech supports cross-species PK design (multiple routes such as SC/IV/IM) and comprehensive metabolite profiling (plasma, urine, bile, feces, tissues), with WinNonlin-based analysis used consistently across modalities. This consistent analytical framework enables comparison of peptide PK behavior alongside small-molecule programs. Building on this ADME–PK foundation for small molecules and peptides, Viva applies modality-specific strategies to antibody programs, where FcRn biology becomes a central determinant of pharmacokinetic behavior. A central technical highlight was Viva Biotech's engineered hFcRn/B2M–MDCK Transwell system for antibody transcytosis, developed to generate a cell-based readout of FcRn-mediated transport and to enable time- and dose-dependent transcytosis measurements. Positioned as a cost- and time-efficient approach for in vitro PK screening, the assay supports evaluation of Fc-engineering variants such as YTE and LALA Fc, and Fc fusion proteins. Importantly, data presented in the webinar demonstrated a strong correlation between cell-based transcytosis readouts and published clinical antibody half-life data (Pearson r > 0.84), supporting its utility for early candidate ranking ahead of in vivo studies. Beyond PK, the webinar highlighted how DMPK decisions become more actionable when paired with mechanistic bioassays. Viva Biotech's immunology in vitro portfolio covers immune-cell activation/differentiation and signaling assays, with platforms including multi-color flow cytometry, multiplex cytokine readouts, reporter assays, and Incucyte imaging systems. In vivo, Viva Biotech described tumor efficacy evaluation capabilities spanning syngeneic and CDX models, with ex vivo analyses supporting TIL assessment, pharmacodynamical biomarkers, and pathology readouts. Together, these approaches enable integrated evaluation of exposure, target engagement, and functional outcomes within disease-relevant contexts. Viva Biotech brings over a decade of early drug discovery experience, with a comprehensive DMPK, pharmacology, and efficacy capabilities. In recent years, this foundation has been further strengthened through facility expansion and deeper integration of antibody PK with disease-focused studies across oncology, autoimmune, metabolic, and other therapeutic areas. In Dr. Cui's framing, Viva Biotech has established a comprehensive DMPK platform spanning multiple drug modalities, embedded within a one-stop service model that connects structure-based discovery with ADME, pharmacokinetics, pharmacology, toxicology, and IND filing—supporting more confident and data-driven development decisions throughout the preclinical stage. For more information about Viva Biotech's Pharmacology & DMPK services, please visit: https://www.vivabiotech.com/cro/pharmacologydmpk
A12 藝術空間
CACO
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
